Mechanisms Involved in Degradation of Human Insulin by Cytosolic Fractions of Human, Monkey, and Rat Liver

Abstract

The degradation of native and 125I-labeled human insulin (HI) was examined in the cytosolic fraction of human, monkey, and rat liver. The purpose of these studies was to provide a species comparison of the interaction of insulin-degrading enzyme (IDE) and protein disulfide isomerase (PDI) in the degradation of HI. Western-blot analysis with monoclonal antibodies indicated the presence of both IDE and PDI in the cytosolic fraction of human and monkey liver. In contrast, rat liver cytosol contained, detectable levels of IDE only. A species comparison of metabolic profiles was performed by fractionating peptide products with reversed-phase high-performance liquid chromatography. After a 60-min incubation, human liver cytosol degraded unlabeled HI into three major products. Two of these peptides coeluted with the products of the incubation of HI with purified rat liver PDI. The three peptides were isolated and determined by NH2-terminal sequence analysis to be intact A chain, B chain, and des(Phe1)-B chain. Human liver cytosol also formed 125I-A chain and 125I-B chain as major products when specifically labeled 125I-HI isomers were used as substrate. Significant proteolytic degradation was observed only when reactions with human liver cytosol were supplemented with Mn2+. In contrast, monkey and rat liver cytosol proteolytically degraded 125I-HI isomers to small peptide fragments. The rat and monkey metabolic profiles were similar to each other and to that observed with Mn(2+)-supplemented human liver cytosol. Proteolysis in monkey and rat was sensitive to inhibition by EDTA.(ABSTRACT TRUNCATED AT 250 WORDS)

Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence

“…The prototype, PDIA1, has two redox-active CGHC domains that have four reactive Cys residues, two substrate binding domains, and a C-terminal ER retention sequence (KDEL) ( Laurindo et al, 2012 ). Although PDIA1 is present mainly in the ER, it is also found in the cytosol ( Parakh and Atkin, 2015 ; Turano et al, 2002 ; Wroblewski et al, 1992 ) and mitochondria ( El Hindy et al, 2014 ) and on the cell surface ( Soares Moretti and Martins Laurindo, 2017 ). Global PDIA1 knockout mice are embryonic lethal, and PDIA1 is dysregulated in neurodegenerative and cardiovascular diseases ( Xu et al, 2014 ).…”

Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum

“…A small amount of PDI has been reported at the surface of some cell types [40], but this has been shown not to reduce ricin holotoxin [41]. Similarly, PDI has been reported to occur in the cytosol [42]. Since there is no rationale for the cytosolic location of this protein, such a claim should be viewed with caution.…”

The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration

“…PDI in the cytosol has been postulated to act as a cofactor with insulin-degrading enzyme (IDE) during insulin metabolism, while acting in concert with reduced GSH to catalyze disulphide bond cleavage [177]. There is also evidence that PDI redistributes away from its ER location into the cytoplasm in pathological conditions.…”